Stanford University
Showing 8,751-8,800 of 36,994 Results
-
Amir Eshel
Edward Clark Crossett Professor of Humanistic Studies and Professor of Comparative Literature
BioAmir Eshel is Edward Clark Crossett Professor of Humanistic Studies. He is Professor of German Studies and Comparative Literature and as of 2019 Director of Comparative Literature and its graduate program. His Stanford affiliations include The Taube Center for Jewish Studies, Modern Thought & Literature, and The Europe Center at Stanford University’s Freeman Spogli Institute for International Studies. He is also the faculty director of Stanford’s research group on The Contemporary and of the Poetic Media Lab at Stanford’s Center for Spatial and Textual Analysis (CESTA). His research focuses on contemporary literature and the arts as they touch on philosophy, specifically on memory, history, political thought, and ethics.
Amir Eshel is the author of Poetic Thinking Today (Stanford University Press, 2019); German translation at Suhrkamp Verlag, 2020). Previous books include Futurity: Contemporary Literature and the Quest for the Past (The University of Chicago Press in 2013). The German version of the book, Zukünftigkeit: Die zeitgenössische Literatur und die Vergangenheit, appeared in 2012 with Suhrkamp Verlag. Together with Rachel Seelig, he co-edited The German-Hebrew Dialogue: Studies of Encounter and Exchange (2018). In 2014, he co-edited with Ulrich Baer a book of essays on Hannah Arendt, Hannah Arendt: zwischen den Disziplinen; and also co-edited a book of essays on Barbara Honigmann with Yfaat Weiss, Kurz hinter der Wahrheit und dicht neben der Lüge (2013).
Earlier scholarship includes the books Zeit der Zäsur: Jüdische Lyriker im Angesicht der Shoah (1999), and Das Ungesagte Schreiben: Israelische Prosa und das Problem der Palästinensischen Flucht und Vertreibung (2006). Amir Eshel has also published essays on Franz Kafka, Hannah Arendt, Paul Celan, Dani Karavan, Gerhard Richter, W.G. Sebald, Günter Grass, Alexander Kluge, Barbara Honigmann, Durs Grünbein, Dan Pagis, S. Yizhar, and Yoram Kaniyuk.
Amir Eshel’s poetry includes a 2018 book with the artist Gerhard Richter, Zeichnungen/רישומים, a work which brings together 25 drawings by Richter from the clycle 40 Tage and Eshel’s bi-lingual poetry in Hebrew and German. In 2020, Mossad Bialik brings his Hebrew poetry collection בין מדבר למדבר, Between Deserts.
Amir Eshel is a recipient of fellowships from the Alexander von Humboldt and the Friedrich Ebert foundations and received the Award for Distinguished Teaching from the School of Humanities and Sciences. -
Neir Eshel, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioDr. Eshel (he/him/his) is a tenure-track Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.
His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the Stanford LGBTQ+ program.
His research interests (www.staarlab.com) include the use of optogenetic, electrophysiological, neuroimaging, and behavioral approaches to probe the neural circuits of reward processing, decision making, and social behavior. He has won multi-year grants from the National Institutes of Health, Burroughs-Wellcome Fund, One Mind Foundation, Sergey Brin Family Foundation, Brain and Behavior Research Foundation, and Simons Foundation to further his research.
Dr. Eshel has published articles on the behavioral roles for dopamine, serotonin, and acetylcholine; the neuroscience of irritability, depression, and addiction; LGBTQ health; and the mechanism of transcranial magnetic stimulation. His work has appeared in Nature, Science, Neuron, Nature Neuroscience, Annual Review of Neuroscience, JAMA, JAMA Psychiatry, Neuropsychopharmacology, Proceedings of the National Academy of Sciences, and the Journal of Neuroscience, among other leading journals. He is a co-inventor on a patent for a new class of drugs for addiction, and also the author of the book Learning: The Science Inside, a publication of the American Association for the Advancement of Science.
He has delivered presentations on the neural circuits of motivated behavior, anger expression in patients with PTSD, how dopamine facilitates learning, and LGBTQ-related topics at keynotes and invited seminars in >10 countries. He is also an associate editor of the Journal of Gay and Lesbian Mental Health, and an ad-hoc reviewer for numerous publications including Nature, Science, Neuron, Nature Communications, JAMA Psychiatry, Biological Psychiatry, and Current Biology.
Dr. Eshel has won honors for his scholarship and advocacy, including the Marshall Scholarship, the One Mind Rising Star Award, the Outstanding Resident Award from the National Institute of Mental Health, the Science and SciLifeLab Grand Prize for Young Scientists, the Freedman Award (honorable mention) from the Brain and Behavior Research Foundation, the Polymath Award from Stanford's psychiatry department, and the National LGBT Health Achievement Award.
He is a member of the American Psychiatric Association, American College of Neuropsychopharmacology, Society of Biological Psychiatry, Association of Gay & Lesbian Psychiatrists, Society for Neuroscience, and other professional associations. He is also an advocate for LGBTQ rights, recently serving as the chair of Stanford's LGBTQ+ Benefits Advocacy Committee.
Prior to Stanford, Dr. Eshel trained and conducted research at the National Institutes of Health, Princeton University, the World Health Organization, University College London, and Harvard University. -
Amir Eskanlou
Postdoctoral Scholar, Earth and Planetary Sciences
BioAmir is a postdoctoral scholar at Stanford Mineral-X. With 15 years of research and industry experience, his background includes the development and optimization of mineral processing flowsheets for copper, phosphate, graphite and rare earth elements (REEs) from primary and secondary resources. At Stanford, he conducts research related to various aspects of critical minerals processing, including AI-driven reagent discovery, uncertainty quantification, circuit design, and optimization of energy and water consumption.
-
Arvin Eslami
Research Associate, Medicine - Med/Immunology & Rheumatology
Current Role at StanfordResearch Associate in the Division of Immunology & Rheumatology at Stanford University School of Medicine.
Responsibilities include supporting immunotherapy and cellular therapy research (CAR-T and TIL), clinical data organization, database management, and contribution to manuscripts, systematic reviews, and meta-analyses.
July 2025 – Present -
Houri Esmaeilkhanian
Affiliate, Ophthalmology Research/Clinical Trials
BioDr. Esmaeilkhanian is an accomplished medical doctor who graduated from Iran University of Medical Sciences (IUMS) in 2018. Her passion for ophthalmology ignited during her medical studies, leading her to a focused research career in this field. After earning her degree, she dedicated her efforts to serving underprivileged communities while continuing her research at the Eye and Ear Research Institute of IUMS. In 2021, she advanced to the Doheny Eye Institute at UCLA, working in Prof. Vas Sadda’s lab, where she made significant contributions to research on diabetic retinopathy and age-related macular degeneration (AMD), further honing her clinical expertise. In March 2023, Dr. Esmaeilkhanian joined Byers Eye Institute, pioneering treatments for corneal injuries using innovative stem cell therapies and hydrogels. Additionally, she plays a crucial role in collaborative clinical studies involving the first FDA-approved AI device for diagnosing diabetic retinopathy impacting patient care in both the Bay Area and underserved regions.
-
Aryan Esmaeili
Instructor (Affiliated), Psych/Public Mental Health & Population Sciences
BioMy research bridges Veteran mental health, brain injury, and computational neuroscience through the development of artificial intelligence (AI), machine learning (ML), and real-world data methods to improve cognitive and rehabilitation outcomes among high-risk Veteran populations. My work focuses on the intersection of traumatic brain injury (TBI), neurodegeneration, substance use disorders, and psychiatric comorbidities, with an emphasis on understanding heterogeneous cognitive trajectories among Veterans. At the C-BRAIN Lab, I collaborate on computational approaches that integrate multimodal electronic health record (EHR) data, neuropsychological assessments, clinical narratives, and longitudinal health outcomes to better characterize cognitive impairment and recovery processes. My current research develops AI/ML phenotyping methods to distinguish potentially reversible cannabis-related cognitive impairment from progressive neurodegenerative disorders using large-scale Veterans Health Administration (VHA) data.
My long-term research goal is to advance precision rehabilitation and cognitive health strategies for Veterans with complex neurological and psychiatric conditions, including TBI and spinal cord injury (SCI). By combining computational neuroscience, causal inference methods, and patient-centered outcomes research, I aim to identify high-risk individuals earlier, improve cognitive outcome measurement, and inform more effective rehabilitation and mental health care strategies within and beyond the VA healthcare system. -
Flint Espil
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Flint Espil researches the etiology and treatment of tic disorders (including Tourette’s), Obsessive-Compulsive Disorder, and body-focused repetitive behaviors. He is interested in how psychosocial factors, the environment, and underlying brain circuitry influence treatment outcomes among individuals seeking treatment. He is also exploring ways to adapt and implement evidence-based mental health approaches in community settings. He is currently collaborating with community-based organizations in East Palo Alto to improve access to care for youth in school settings.
-
Pedro David Espinoza
Graduate, Vice Provost and Dean of Research
BioPedro David Espinoza is a TEDx speaker, entrepreneur, investor, and author. In 2014, Pedro became the Founder & CEO of SmileyGo, an app that helped companies invest smarter. SmileyGo indexed the data of 1.5 million NGOs in addition to having users in 30 countries. Incubated at SkyDeck, his software startup gained funding from 1517 Fund, Frank Baxter, Jack Larson, and Berkeley Haas Seed Fund. In 2017, Janet Napolitano awarded Pedro The University of California Entrepreneur Winner. In 2018, Pedro founded Pan Peru USA, a venture that empowers women to become entrepreneurs. With the support from Fortune 500s, Pan Peru has empowered 100 female entrepreneurs. In 2019, Pedro wrote a book with Jorge Titinger with contributions from Eric Schmidt, Reed Hastings, and Dan Schulman. Pedro's book – Differences That Make A Difference – attracted 100 CEOs as contributors such as Pat Gelsinger who wrote the foreword. His book received the 2020 Best Business Book Award by Latino International.
Educated at Berkeley, Stanford, and Harvard, Pedro interned as a mechanic during high school. In 2010, Pedro launched his music singles on Apple and Spotify. Pedro is the Founder & General Partner of PDE Ventures, a venture capital fund that has 20 startup investments such as Robot.com, Mocafi and Happioh. He is a limited partner at venture capital funds such as Cortado Ventures, GoodLight Capital, and 1Flourish Capital. In 2021, The Silicon Valley Business Journal recognized him as a Latin Business Leadership Honoree.
In 2016, Pedro became a distinguished keynote speaker. Microsoft, Google, and Meta are some of the companies he has given speeches. Pedro has given 300 keynotes by sharing his immigrant entrepreneurial story. In 2020, he became a lecturer at Tecnologico de Monterrey to teach entrepreneurship and engineering. In 2024, Pedro's second book – The Real ROI: Return on Inclusion – included contributions from 50 prominent CEOs, such as Michael Dell, John Hennessy, and Shellye Archambeau.
Pedro has been profiled in USA Today, Forbes, Los Angeles Tribune, MSN, Nasdaq, Yahoo Finance, CBS, Univision, Stanford Daily, Hispanic Shark Tank, Times of Israel, KRON-TV, Hispanic Executive, Latin America Reports, Berkeley Haas Magazine, Al Día News, and Latino Leaders Magazine. In 2017, The Voice of America named Pedro "The Robinhood of Technology”. Pedro serves on the board of directors of Notre Dame de Namur University, CuriOdyssey, Melzi Surgical, Silicon Valley Tech Academy, ActAware, synergEV, Hertz Peru, GESA, and Institute for International Medicine.
In 2017, Pedro gave his TEDx Talk – Build the Bridge – sharing his American Dream story having 22,000 views. In 2020, Pedro joined the Silicon Valley Leadership Group as the VP of Business Development. In 2021, Pedro was elected as the Vice Curator for Global Shapers in Palo Alto by the World Economic Forum. In 2022, Pedro got accepted to the LinkedIn Creator Accelerator Program as a Technology & Innovation Awardee having 23,000 followers. Later, he became the CMO of Ever Medical Technologies to lead the marketing team. In 2023, Pedro received the NextGen 30 Under 30 Award presented by Goldman Sachs. Later, Pedro was appointed to the Advisory Board of 1t.org of the World Economic Forum. In 2024, Pedro received the Silicon Valley 40 Under 40 Award presented by BMO. Pedro’s Pan Peru has given 10,000 children access to STEM education and reforested 15,000 trees. In 2025, Pedro joined the Young Presidents’ Organization (YPO) as Vice Chairman of Autoespar. Later that year, Pedro received the National Healthcare Service Award by INMED for his dedication to social impact, climate, and education through Pan Peru. As of 2025, Pedro’s books have been featured in the Berkeley Engineering and Stanford Business libraries. Pedro has received recognition for his success, he has received the 2021-2022 and 2022-2023 HITEC 100 Awards - which features the 100 most influential Latinos. -
Carlos O. Esquivel, M.D., Ph.D.,FACS
Arnold and Barbara Silverman Professor in Pediatric Transplantation and Professor of Surgery (Abdominal Transplantation) and of Pediatrics (Gastroenterology, Hepatology and Nutrition)
Current Research and Scholarly Interests1) Induction of immunotolerance
2) Rejection of liver and intestinal transplantation.
3) Clinical outcomes of children with unresectable liver tumors. -
Micaela Esquivel, MD, FACS
Clinical Associate Professor, Surgery - General Surgery
BioDr. Micaela Esquivel is a board-certified, fellowship-trained surgeon specializing in bariatric (weight loss) and minimally invasive surgery at Stanford Health Care. She is also a clinical associate professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Esquivel specializes in foregut (upper digestive tract) surgery and bariatric surgery using robotic and therapeutic endoscopic approaches. She developed the Bariatric Endoscopy Program at Stanford Health Care and treats patients with hiatal hernias, reflux, and motility disorders of the esophagus and stomach.
As a bariatric surgeon, Dr. Esquivel specializes in endobariatric procedures, such as endoscopic sleeve gastroplasty and intragastric balloon. She also treats patients who have regained weight after bariatric surgery. This includes providing endoscopic sleeve revisions and reductions, as well as transoral outlet reductions for patients who have had gastric bypass.
Dr. Esquivel is passionate about helping everyone access the care they need. She values work that minimizes disparities and promotes health equity. She has studied access to surgical care in California and countries around the world, including Zambia and Guatemala. Her current work focuses on disparities in bariatric surgery.
Dr. Esquivel has presented her research at many conferences, including the American College of Surgeons Clinical Congress and the American Society for Metabolic and Bariatric Surgery (ASMBS). In addition, she has written more than two dozen articles on topics such as surgical outcomes, weight loss before bariatric surgery, and global access to surgical care. Her work has appeared in many prominent journals, including JAMA, The Lancet, World Journal of Surgery, and Journal of Surgical Research.
Dr. Esquivel is a fellow of the American College of Surgeons. She is also an active member of ASMBS, the American Foregut Society, and the Society of American and Gastrointestinal and Endoscopic Surgeons. -
Amir Esrafilian
Visiting Postdoctoral Scholar, Bioengineering
Affiliate, Wu Tsai Human Performance AllianceBioContact info: amires@stanford.edu
